Science Corporation implants its vision-restoring chip in first Stargardt disease patient
Science Corporation, led by former Neuralink president and co-founder Max Hodak, has implanted its PRIMA vision-restoring chip in its first Stargardt disease patient. Speaking on stage at TechCrunch Disrupt, Hodak framed the work as part of the company's path toward a next-generation brain-computer interface (BCI).
